Literature DB >> 17195135

Genetic factors in pulmonary fibrotic disorders.

Roland M du Bois1.   

Abstract

Identifying genetic determinants of pulmonary fibrotic disorders remains at an early stage of evolution. It is now well-recognized that "pulmonary fibrosis" covers a broad range of lung diseases, including most topically the idiopathic interstitial pneumonias that have been classified recently. Additionally, it is recognized that the fibrosing lung disorders that are seen in the rheumatological diseases, notably systemic sclerosis, are quite different from those of the idiopathic variety. Defining clinical phenotype is an important prerequisite to the identification of genetic determinants associated with individual diseases, but it is important to acknowledge that there may be determinants of global lung fibrosis and that other factors drive diseases down specific, more individual disease pathways. Current association studies are encouraging but far from conclusive for a variety of reasons, including small numbers, poor controls, and curious candidate selection. The results of the ongoing multicenter familial linkage study in the United States should provide several candidate genes that will spur further studies of sporadic disease in, it is hoped, a more internationally coordinated effort.

Entities:  

Mesh:

Year:  2006        PMID: 17195135     DOI: 10.1055/s-2006-957330

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  5 in total

1.  Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.

Authors:  Rongrong Wei; Chong Li; Min Zhang; Yava L Jones-Hall; Jamie L Myers; Imre Noth; Wanqing Liu
Journal:  Transl Res       Date:  2013-12-17       Impact factor: 7.012

Review 2.  Strategies for treating idiopathic pulmonary fibrosis.

Authors:  R M du Bois
Journal:  Nat Rev Drug Discov       Date:  2010-01-22       Impact factor: 84.694

3.  Fibrogenesis of parenchymal organs.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

Review 4.  Ecogenomics of respiratory diseases of public health significance.

Authors:  Stavros Garantziotis; David A Schwartz
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

5.  The association between transforming growth factor beta1 polymorphism and susceptibility to pulmonary fibrosis: A meta-analysis (MOOSE compliant).

Authors:  Lili Xin; Miao Jiang; Guangbao Su; Miao Xie; Hui Chen; Xiao Liu; Muge Xu; Geng Zhang; Jiening Gong
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.